128
Participants
Start Date
August 14, 2018
Primary Completion Date
April 18, 2023
Study Completion Date
June 1, 2023
Lanifibranor
The film-coated tablet contains 400 mg of the active ingredient lanifibranor (IVA337) for an immediate release formulation. Participants receive 800mg/ day
Placebo
Film-coated tablets with a core containing 900 mg of a physical mixture of lactose monohydrate, microcrystalline cellulose, pre-gelatinized starch and magnesium stearate serve as placebo.
University of Florida, Gainesville
Collaborators (1)
Inventiva Pharma
INDUSTRY
University of Florida
OTHER